Akin Advises Phoenix on £200 Million Continuation Fund

September 24, 2024

Reading Time : 1 min

Contact:

Jacinta O'Shea-Ramdeholl

Director of Communications

Scott Wasserman

Senior Media Relations Manager

(London) – Akin advised Phoenix Equity Partners (Phoenix) on the formation of a £200 million continuation fund through which Phoenix extended its partnership with large-scale trade exhibitions company, Nineteen Group, and private pay dental group, Envisage Dental. The continuation fund was led by Kline Hill Partners and co-led by Ares Management.

The newly established Growth Partnership Fund has acquired Nineteen and Envisage from a Phoenix flagship fund. The transaction enables the two businesses to continue their rapid market growth, with a combined enterprise value of now close to £450 million.

The cross-practice Akin team was led by investment management partners Daniel Quinn and Simon Ellis and included investment management counsel Chris Jeanes and Michelle Liptakova and associate Matthew Allan, and tax partner Stuart Alter and counsel Peretz Riesenberg.

To learn more about this transaction, please click here.

Akin is a leading international law firm with more than 900 lawyers in offices throughout the United States, Europe, Asia and the Middle East.

# # #

Share This Insight

Related Services, Sectors, and Regions

© 2024 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.